Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD20 IgG with similar domains from an anti-CD22 antibody via short peptide linkers, or vice versa. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Fv-IgG) (BSDG-049). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS